Get the Stockscreener App
4.47
1.76%
-0.08
After Hours:
4.53
0.06
+1.34%
Sonoma Pharmaceuticals Inc stock is traded at $4.47, with a volume of 31,548.
It is down -1.76% in the last 24 hours and up +49.00% over the past month.
Sonoma Pharmaceuticals Inc is a specialty pharmaceutical company operating in the United States. It is engaged in identifying, developing, and commercializing differentiated therapies for patients living with chronic skin conditions. The company focuses on the development and commercialization of therapeutic solutions in medical dermatology to treat skin conditions, such as acne, atopic dermatitis, and scarring. The key products of the company are Celacyn, Ceramax Skin Barrier Cream, Mondoxyne, Alevicyn, SebuDerm, Microcyn, and Microcyn which are available for various skin treatments such as scars, itchy skin, minor skin irritations, rashes, and others. The company derives revenue from the sale of products in the United States, Latin America, Europe, Asia, and other countries.
See More
Previous Close:
$4.55
Open:
$4.52
24h Volume:
31,548
Relative Volume:
0.03
Market Cap:
$7.35M
Revenue:
$12.31M
Net Income/Loss:
$-5.08M
P/E Ratio:
-4.7553
EPS:
-0.94
Net Cash Flow:
$-5.20M
1W Performance:
-5.50%
1M Performance:
+49.00%
6M Performance:
+27.35%
1Y Performance:
+41.01%
1-Day Range:
$4.411
$4.58
1-Week Range:
$4.31
$4.70
52-Week Range:
$1.75
$6.9199
Sonoma Pharmaceuticals Inc Stock (SNOA) Company Profile
Name
Sonoma Pharmaceuticals Inc
Sector
Phone
800-759-9305
Address
5445 CONESTOGA COURT, SUITE 150, BOULDER, CA
Compare SNOA with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
SNOA
Sonoma Pharmaceuticals Inc
|
4.47 | 7.69M | 12.31M | -5.08M | -5.20M | -0.94 |
|
ZTS
Zoetis Inc
|
148.20 | 66.22B | 9.39B | 2.62B | 2.22B | 5.81 |
|
TAK
Takeda Pharmaceutical Co Adr
|
15.10 | 48.29B | 29.96B | 957.25M | 4.77B | 0.304 |
|
HLN
Haleon Plc Adr
|
9.81 | 43.99B | 14.26B | 1.98B | 2.47B | 0.4347 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
19.93 | 22.45B | 16.70B | -157.13M | 1.19B | -0.155 |
|
UTHR
United Therapeutics Corp
|
405.02 | 17.93B | 2.99B | 1.21B | 1.13B | 25.06 |
Sonoma Pharmaceuticals Inc Stock (SNOA) Latest News
Is Sonoma Pharmaceuticals Inc. stock entering bullish territoryMarket Sentiment Report & Reliable Price Action Trade Plans - newser.com
Can Sonoma Pharmaceuticals Inc. recover in the next quarterEarnings Miss & Low Drawdown Momentum Trade Ideas - newser.com
Is Sonoma Pharmaceuticals Inc. showing signs of accumulationTrade Entry Report & Risk Adjusted Swing Trade Ideas - newser.com
Sonoma Pharmaceuticals Inc. stock trend outlook and recovery pathInsider Selling & Stock Portfolio Risk Management - newser.com
Sonoma Pharmaceuticals Inc. stock trend forecast2025 Volume Leaders & Fast Gain Swing Trade Alerts - newser.com
Will Sonoma Pharmaceuticals Inc. continue its uptrendJuly 2025 Breakouts & Reliable Volume Spike Alerts - newser.com
How to escape a deep drawdown in Sonoma Pharmaceuticals Inc.Quarterly Growth Report & Verified Trade Idea Suggestions - newser.com
Momentum divergence signals in Sonoma Pharmaceuticals Inc. chart2025 Market Overview & Real-Time Volume Analysis Alerts - newser.com
Published on: 2025-09-14 10:14:27 - newser.com
Can machine learning forecast Sonoma Pharmaceuticals Inc. recoveryTrade Risk Assessment & Low Risk High Win Rate Picks - newser.com
Statistical indicators supporting Sonoma Pharmaceuticals Inc.’s strengthMarket Risk Analysis & Long-Term Safe Investment Plans - Newser
Multi asset correlation models including Sonoma Pharmaceuticals Inc.Dip Buying & Free Reliable Trade Execution Plans - Newser
Has Sonoma Pharmaceuticals Inc. formed a bullish divergenceForecast Cut & Long-Term Growth Plans - Newser
Is a relief rally coming for Sonoma Pharmaceuticals Inc. holdersBuy Signal & Free Community Supported Trade Ideas - Newser
Best data tools to analyze Sonoma Pharmaceuticals Inc. stock2025 Support & Resistance & Growth Focused Investment Plans - Newser
Published on: 2025-09-12 16:42:59 - Newser
How to track smart money flows in Sonoma Pharmaceuticals Inc.Weekly Trade Report & AI Forecasted Entry and Exit Points - Newser
Using R and stats models for Sonoma Pharmaceuticals Inc. forecastingMarket Growth Report & Reliable Entry Point Trade Alerts - Newser
Will a bounce in Sonoma Pharmaceuticals Inc. offer an exit2025 Market Overview & Breakout Confirmation Alerts - Newser
Is now a turning point for Sonoma Pharmaceuticals Inc.Earnings Beat & Technical Pattern Alert System - Newser
Leading vs lagging indicators on Sonoma Pharmaceuticals Inc. performanceWeekly Trade Summary & Consistent Profit Focused Trading Strategies - Newser
Using AI based signals to follow Sonoma Pharmaceuticals Inc.Market Risk Analysis & Weekly High Potential Stock Alerts - Newser
Published on: 2025-09-12 01:06:46 - newser.com
What’s next for Sonoma Pharmaceuticals Inc. stock priceMarket Volume Summary & Entry and Exit Point Strategies - Newser
Using data tools to time your Sonoma Pharmaceuticals Inc. exitTrade Volume Summary & High Accuracy Trade Signal Alerts - Newser
Chart based exit strategy for Sonoma Pharmaceuticals Inc.Portfolio Growth Summary & Advanced Swing Trade Entry Alerts - Newser
Does Sonoma Pharmaceuticals Inc. show high probability of reboundWeekly Investment Report & Stock Portfolio Risk Management - Newser
Using Ichimoku Cloud for Sonoma Pharmaceuticals Inc. technicalsJuly 2025 Opening Moves & Fast Moving Trade Plans - Newser
Can technical indicators confirm Sonoma Pharmaceuticals Inc.’s reversalNew Guidance & AI Powered Market Trend Analysis - Newser
Is it too late to sell Sonoma Pharmaceuticals Inc.July 2025 Selloffs & Fast Momentum Stock Entry Tips - Newser
When is the best time to exit Sonoma Pharmaceuticals Inc.Dividend Hike & Weekly High Return Stock Forecasts - Newser
How to recover losses in Sonoma Pharmaceuticals Inc. stockTrade Risk Summary & Fast Exit and Entry Strategy Plans - Newser
Should you wait for a breakout in Sonoma Pharmaceuticals Inc.Analyst Downgrade & Entry Point Confirmation Signals - Newser
Sonoma Pharmaceuticals Inc Stock (SNOA) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.67%
0.04%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):